MLICM
MEDP icon

Metropolitan Life Insurance Company (MetLife)’s Medpace MEDP Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,371
Closed -$258K – 2491
2023
Q1 		$258K Sell
1,371
-188
-12% -$38.9K 0.01% 584
2022
Q4 		$331K Buy
1,559
+34
+2% +$6.79K 0.01% 549
2022
Q3 		$240K Sell
1,525
-136
-8% -$21.7K 0.01% 612
2022
Q2 		$249K Sell
1,661
-159
-9% -$23K 0.01% 629
2022
Q1 		$298K Sell
1,820
-10,126
-85% -$1.67M 0.01% 649
2021
Q4 		$2.6M Sell
11,946
-305
-2% -$63.9K 0.04% 414
2021
Q3 		$2.32M Sell
12,251
-437
-3% -$79.7K 0.03% 440
2021
Q2 		$2.24M Buy
12,688
+510
+4% +$88K 0.03% 469
2021
Q1 		$2M Sell
12,178
-76
-0.6% -$11.6K 0.03% 516
2020
Q4 		$1.71M Sell
12,254
-69
-0.6% -$8.7K 0.03% 555
2020
Q3 		$1.38M Buy
12,323
+3,963
+47% +$458K 0.02% 581
2020
Q2 		$778K Sell
8,360
-143
-2% -$12.2K 0.01% 895
2020
Q1 		$624K Sell
8,503
-394
-4% -$34.2K 0.01% 933
2019
Q4 		$748K Sell
8,897
-177
-2% -$13.7K 0.01% 1082
2019
Q3 		$763K Buy
9,074
+1,526
+20% +$115K 0.01% 1021
2019
Q2 		$494K Buy
7,548
+417
+6% +$24K 0.01% 1308
2019
Q1 		$421K Hold
7,131
– – 0.01% 1417
2018
Q4 		$377K Hold
7,131
– – 0.01% 1394
2018
Q3 		$427K Buy
7,131
+2,987
+72% +$163K 0.01% 1484
2018
Q2 		$178K Buy
4,144
+1,507
+57% +$60.9K ﹤0.01% 2018
2018
Q1 		$92.1K Hold
2,637
– – ﹤0.01% 2326
2017
Q4 		$96K Sell
2,637
-2,830
-52% -$99.2K ﹤0.01% 2331
2017
Q3 		$174K Buy
+5,467
New +$167K ﹤0.01% 2336
2017
Q2 		– Sell
-6,665
Closed -$199K – 2579
2017
Q1 		$199K Hold
6,665
– – ﹤0.01% 2271
2016
Q4 		$240K Buy
+6,665
New +$222K ﹤0.01% 2240

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MEDP Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Medpace (MEDP) in Q2 2023, closing a stake of 1,371 shares — an estimated $258K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MEDP in Q4 2016 and held it in 25 quarters. The position peaked at $2.6M in Q4 2021. 464 funds tracked by Wall St. Rank hold MEDP as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Medpace position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,371 Medpace shares in Q2 2023, an estimated $258K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Medpace in Q4 2016 and held it in 25 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Medpace position peaked at $2.6M in Q4 2021.
  • 464 funds tracked by Wall St. Rank held Medpace as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.